Pettyjohn Wood & White’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $734K | Sell |
2,085
-5
| -0.2% | -$1.78K | 0.12% | 114 |
|
|
2025
Q4 | $684K | Buy |
2,090
+5
| +0.2% | +$1.59K | 0.11% | 117 |
|
|
2025
Q3 | $589K | Sell |
2,085
-161
| -7% | -$46.7K | 0.1% | 120 |
|
|
2025
Q2 | $627K | Sell |
2,246
-69
| -3% | -$19.5K | 0.11% | 114 |
|
|
2025
Q1 | $721K | Sell |
2,315
-5
| -0.2% | -$1.48K | 0.14% | 103 |
|
|
2024
Q4 | $605K | Sell |
2,320
-55
| -2% | -$16.3K | 0.11% | 112 |
|
|
2024
Q3 | $765K | Sell |
2,375
-15
| -0.6% | -$4.91K | 0.14% | 97 |
|
|
2024
Q2 | $747K | Sell |
2,390
-232
| -9% | -$68.2K | 0.15% | 93 |
|
|
2024
Q1 | $746K | Buy |
2,622
+50
| +2% | +$14.6K | 0.15% | 90 |
|
|
2023
Q4 | $741K | Hold |
2,572
| – | – | 0.16% | 87 |
|
|
2023
Q3 | $691K | Buy |
2,572
+347
| +16% | +$86.6K | 0.16% | 86 |
|
|
2023
Q2 | $494K | Buy |
2,225
+150
| +7% | +$34.8K | 0.11% | 104 |
|
|
2023
Q1 | $502K | Buy |
2,075
+83
| +4% | +$20.4K | 0.12% | 105 |
|
|
2022
Q4 | $523K | Sell |
1,992
-50
| -2% | -$13.4K | 0.13% | 104 |
|
|
2022
Q3 | $460K | Sell |
2,042
-10
| -0.5% | -$2.42K | 0.12% | 107 |
|
|
2022
Q2 | $499K | Buy |
2,052
+10
| +0.5% | +$2.45K | 0.12% | 107 |
|
|
2022
Q1 | $494K | Sell |
2,042
-122
| -6% | -$28K | 0.11% | 107 |
|
|
2021
Q4 | $487K | Sell |
2,164
-71
| -3% | -$15K | 0.1% | 113 |
|
|
2021
Q3 | $475K | Sell |
2,235
-50
| -2% | -$11.5K | 0.11% | 107 |
|
|
2021
Q2 | $557K | Sell |
2,285
-345
| -13% | -$84.9K | 0.12% | 102 |
|
|
2021
Q1 | $654K | Sell |
2,630
-356
| -12% | -$84.9K | 0.16% | 93 |
|
|
2020
Q4 | $687K | Sell |
2,986
-37
| -1% | -$8.53K | 0.18% | 89 |
|
|
2020
Q3 | $768K | Buy |
3,023
+53
| +2% | +$13.1K | 0.22% | 78 |
|
|
2020
Q2 | $701K | Hold |
2,970
| – | – | 0.22% | 80 |
|
|
2020
Q1 | $602K | Sell |
2,970
-65
| -2% | -$14.2K | 0.22% | 79 |
|
|
2019
Q4 | $732K | Sell |
3,035
-125
| -4% | -$27.6K | 0.21% | 82 |
|
|
2019
Q3 | $612K | Buy |
3,160
+387
| +14% | +$74.3K | 0.19% | 87 |
|
|
2019
Q2 | $511K | Hold |
2,773
| – | – | 0.16% | 94 |
|
|
2019
Q1 | $527K | Sell |
2,773
-278
| -9% | -$53.1K | 0.17% | 92 |
|
|
2018
Q4 | $594K | Hold |
3,051
| – | – | 0.22% | 83 |
|
|
2018
Q3 | $632K | Buy |
3,051
+100
| +3% | +$19.7K | 0.21% | 88 |
|
|
2018
Q2 | $545K | Sell |
2,951
-575
| -16% | -$102K | 0.19% | 90 |
|
|
2018
Q1 | $601K | Sell |
3,526
-3,059
| -46% | -$562K | 0.22% | 86 |
|
|
2017
Q4 | $1.15M | Sell |
6,585
-625
| -9% | -$111K | 0.41% | 69 |
|
|
2017
Q3 | $1.34M | Sell |
7,210
-561
| -7% | -$99.4K | 0.5% | 61 |
|
|
2017
Q2 | $1.34M | Sell |
7,771
-504
| -6% | -$82K | 0.5% | 60 |
|
|
2017
Q1 | $1.36M | Sell |
8,275
-130
| -2% | -$21.6K | 0.5% | 62 |
|
|
2016
Q4 | $1.23M | Sell |
8,405
-400
| -5% | -$60.2K | 0.48% | 61 |
|
|
2016
Q3 | $1.47M | Buy |
8,805
+50
| +0.6% | +$8.46K | 0.7% | 49 |
|
|
2016
Q2 | $1.33M | Buy |
8,755
+115
| +1% | +$17.9K | 0.53% | 59 |
|
|
2016
Q1 | $1.29M | Buy |
8,640
+4,271
| +98% | +$635K | 0.53% | 60 |
|
|
2015
Q4 | $709K | Buy |
4,369
+370
| +9% | +$58.2K | 0.3% | 77 |
|
|
2015
Q3 | $553K | Buy |
3,999
+620
| +18% | +$97.7K | 0.25% | 80 |
|
|
2015
Q2 | $519K | Buy |
+3,379
| New | +$541K | 0.22% | 87 |
|
Other funds holding AMGN
VCM
VPM
Pettyjohn Wood & White's AMGN Position: Q1 2026 in Review
Pettyjohn Wood & White reduced its Amgen (AMGN) stake by 0.24% in Q1 2026, selling an estimated $1.78K and leaving 2,085 shares worth $734K. The position accounts for 0.12% of the portfolio, ranked #114.
Pettyjohn Wood & White first reported a position in AMGN in Q2 2015 and has held it in 44 quarters since. The position peaked at $1.47M in Q3 2016. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Pettyjohn Wood & White held 2,085 shares of Amgen worth $734K as of Q1 2026.
- Pettyjohn Wood & White sold 5 Amgen shares in Q1 2026, an estimated $1.78K.
- Amgen made up 0.12% of Pettyjohn Wood & White's portfolio in Q1 2026, its #114 holding.
- Pettyjohn Wood & White first reported a position in Amgen in Q2 2015 and has held it in 44 quarters since.
- Pettyjohn Wood & White's Amgen position peaked at $1.47M in Q3 2016.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Pettyjohn Wood & White's 13F filing for Q1 2026, filed 15 May 2026.